These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3168396)

  • 21. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
    Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
    Zeeh J; Lange H; Bosch J; Pohl S; Loesgen H; Eggers R; Navasa M; Chesta J; Bircher J
    Gastroenterology; 1988 Sep; 95(3):749-59. PubMed ID: 3396820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.
    Soons PA; Kroon JM; Breimer DD
    J Clin Pharmacol; 1990 Aug; 30(8):693-8. PubMed ID: 2401748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The trans-hepatic extraction of nifedipine.
    Challenor VF; Waller DG; Renwick AG; Gruchy BS; George CF
    Br J Clin Pharmacol; 1987 Oct; 24(4):473-7. PubMed ID: 3689628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic extraction of morphine is impaired in cirrhosis.
    Crotty B; Watson KJ; Desmond PV; Mashford ML; Wood LJ; Colman J; Dudley FJ
    Eur J Clin Pharmacol; 1989; 36(5):501-6. PubMed ID: 2753069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.
    Vinel JP; Caucanas JP; Calès P; Suduca JM; Voigt JJ; Pascal JP
    J Hepatol; 1988 Oct; 7(2):186-92. PubMed ID: 3192922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cimetidine on hepatic drug elimination in cirrhosis.
    Nelson DC; Avant GR; Speeg KV; Hoyumpa AM; Schenker S
    Hepatology; 1985; 5(2):305-9. PubMed ID: 3979962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease.
    Dunk AA; Jenkins WJ; Burroughs AK; Walt RP; Osuafor TO; Sherlock S; Mackie S; Dick R
    Br J Clin Pharmacol; 1983 Aug; 16(2):117-20. PubMed ID: 6137230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M; García-Pagán JC; Bosch J; Rodés J
    Med Clin (Barc); 1992 Feb; 98(8):290-4. PubMed ID: 1560714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral near infrared spectroscopy for the measurement of indocyanine green elimination in cirrhosis.
    Therapondos G; Plevris JN; Stanley AJ; Peters CJ; Teig M; Hayes PC
    Aliment Pharmacol Ther; 2000 Jul; 14(7):923-8. PubMed ID: 10886049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
    Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
    Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of verapamil and nifedipine on the systemic hemodynamics and liver macro- and microcirculations in rats with acute massive blood loss].
    Kovalenko NIa; Matsievskiĭ DD
    Biull Eksp Biol Med; 1993 Nov; 116(11):469-72. PubMed ID: 8312530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil disposition in liver disease and intensive-care patients: kinetics, clearance, and apparent blood flow relationships.
    Woodcock BG; Rietbrock I; Vöhringer HF; Rietbrock N
    Clin Pharmacol Ther; 1981 Jan; 29(1):27-34. PubMed ID: 7460471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
    Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.